Expression of thrombopoietin and its rec
β
Kerim Kaban; Hagop Kantarjian; Moshe Talpaz; Susan O'Brien; Jorge Cortes; Franci
π
Article
π
2000
π
John Wiley and Sons
π
English
β 97 KB
π 1 views
BACKGROUND. Chronic myelogenous leukemia (CML) represents a paradigm of the stepwise increment in disease aggressiveness, resistance to therapy, and transformation. Thrombopoietin (TPO) and its receptor, c-mpl, support the proliferation of multiple types of immature hematopoietic progenitor cells, a